Published in Cancer Weekly, May 18th, 2010
"With a median follow-up of 6 years, 42 additional cases of CIN2+ were identified; women who were...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.